Gene regulation induced in the C57BL/6J mouse retina by hyperoxia: a temporal microarray study by Natoli, Riccardo et al.
Gene regulation induced in the C57BL/6J mouse retina by
hyperoxia: a temporal microarray study
Riccardo Natoli,1,2 Jan Provis,1,2 Krisztina Valter,1,2 Jonathan Stone1,2,3
1ARC Centre of Excellence in Vision Science, The Australian National University, Canberra, Australia; 2Visual Sciences Group,
School of Biology, The Australian National University, Canberra, Australia; 3Save Sight Institute and Discipline of Physiology,
University of Sydney, Sydney, Australia
Purpose: Hyperoxia is specifically toxic to photoreceptors, and this toxicity may be important in the progress of retinal
dystrophies. This study examines gene expression induced in the C57BL/6J mouse retina by hyperoxia over the 14-day
period during which photoreceptors first resist, then succumb to, hyperoxia.
Methods: Young adult C57BL/6J mice were exposed to hyperoxia (75% oxygen) for up to 14 days. On day 0 (control),
day 3, day 7, and day 14, retinal RNA was extracted and processed on Affymetrix GeneChip® Mouse Genome 430 2.0
arrays. Microarray data were analyzed using GCOS Version 1.4 and GeneSpring Version 7.3.1. For 15 genes, microarray
data were confirmed using relative quantitative real-time reverse transcription polymerase chain reaction techniques.
Results: The overall numbers of hyperoxia-regulated genes increased monotonically with exposure. Within that increase,
however, a distinctive temporal pattern was apparent. At 3 days exposure, there was prominent upregulation of genes
associated with neuroprotection. By day 14, these early-responsive genes were downregulated, and genes related to cell
death were strongly expressed. At day 7, the regulation of these genes was mixed, indicating a possible “transition period”
from stability at day 3 to degeneration at day 14. When functional groupings of genes were analyzed separately, there was
significant regulation in genes responsive to stress, genes known to cause human photoreceptor dystrophies and genes
associated with apoptosis.
Conclusions: Microarray analysis of the response of the retina to prolonged hyperoxia demonstrated a temporal pattern
involving early neuroprotection and later cell death, and provided insight into the mechanisms involved in the two phases
of response. As hyperoxia is a consistent feature of the late stages of photoreceptor degenerations, understanding the
mechanisms of oxygen toxicity may be important therapeutically.
Retinal dystrophies are a diverse group of conditions with
the common feature of photoreceptor degeneration. Many
have a genetic basis [1] but environmental factors, such as
oxygen [2] and ambient light [3–6], play a role in determining
their phenotype. This study concerns the impact of excess
oxygen on nondegenerative photoreceptors in the C57BL/6
mouse. Oxygen levels in the outer (photoreceptor) layers of
retina vary more widely than in the inner layers, or in other
regions of the central nervous system [7], because of the lack
of autoregulation in the choroidal circulation [8]. Hyperoxia
is specifically and directly toxic to photoreceptors [9–13], and
oxygen levels in outer retina rise in probably all forms of
retinal  degeneration,  as  the  photoreceptor  population  is
depleted [14–16]. As a consequence, hyperoxia may play a
role  in  the  progression  of  photoreceptor  degenerations,
whatever the initial cause.
The genes that regulate the response of photoreceptors to
hyperoxia are not well understood. The effect of hyperoxia on
several housekeeping genes [17] and the early response of the
protective Oxr1 gene [18] have been described, and a strong
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genetic determinant of resistance to hyperoxic toxicity has
been traced to chromosome 6 in the A/J mouse strain [19].
However, to date no study has described global changes in
retinal  gene  expression  of  genes  in  response  to  sustained
hyperoxia. This paper describes changes in gene expression
over a 14-day period previously demonstrated as necessary
for the induction of photoreceptor death in the C57BL/6J
mouse [10,19].
METHODS
Rearing conditions: C57BL/6J mice were used because of the
vulnerability of their photoreceptors to hyperoxia. Mice were
raised in dim (5 lux) cyclic illumination (12 h:12 h light-dark
cycle).  These  levels  of  lighting  were  maintained  during
exposure  to  hyperoxia.  Three-month-old  adult  mice  were
placed in a clear Plexiglass chamber and exposed to normoxia
(control – 0 days) or 75% oxygen for 3, 7, or 14 days. Oxygen
levels  were  maintained  using  a  Oxycycler  feedback-
controlled device (Biospherix, Lacona, NY). Animals were
treated in accordance with the ARVO Statement for the Use
of Animals in Ophthalmic and Vision Research.
RNA extraction and analysis: RNA extraction was performed
using a combination of TRIzol Reagent (Cat# 15596–026;
Invitrogen, Carlsbad, CA) and RNAqueous-micro kit (Cat#
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19831931; Ambion, Foster City, CA). TRizol was used to extract
the RNA, and the RNAqueous kit was used to purify and
DNase-treat the RNA.
Animals were sacrificed by cervical dislocation and the
retinas removed. For each time point (0, 3, 7, and 14 days), 12
retinas (from three males and three females) were pooled and
placed into a 1.5 ml tube containing 200 µl of TRIzol and
homogenized on ice. Following homogenization, a further
660 µl of TRIzol and 160 µl of chloroform were added to the
tube. The tube was vortexed for 20 s and allowed to stand for
7 min at room temperature. The tubes were centrifuged at
13,000x g for 10 min at 4 °C. The supernatant was then
removed and placed into a clean 1.5 ml tube with half its
volume of 100% ethanol. The tube was vortexed briefly before
its contents underwent purification (Part C. RNA Isolation,
Ambion  Protocol)  and  DNase  treatment  (Part  D,  Ambion
Protocol) as detailed in the RNAqueous-micro kit manual.
Purified  DNAase-treated  RNA  was  analyzed  on  a
ND-1000  spectrophotometer  (Nanodrop  Technologies,
Wilmington,  DE)  and  a  2100-Bioanalyzer  (Agilent
Technologies, Santa Clara, CA), to determine the quantity and
purity of the sample. RNA samples were used only if the
260/280 ratio was above 1.9 and the RIN (RNA integrity
number) was greater than 8.5.
Microarray analysis: To study the changes in gene expression
induced by hyperoxia, we used 8 Affymetrix (Santa Clara,
CA)  Mouse  Genome  430  2.0  arrays.  These  microarrays
contain over 39,000 transcripts representing 34,000 genes.
Labeling,  hybridization,  washing,  and  scanning  of  the
microarray  were  performed  at  the  ACRF  Biomolecular
Resource  Facility  at  the  John  Curtin  School  of  Medical
Research,  Australian  National  University,  following  the
manufacturers’ specifications (Affymetrix). The arrays were
scanned on the GCS 3000 Affymetrix high resolution scanner
and analyzed using the GeneChip Operating Software v1.4
(GCOS;  Affymetrix)  and  GeneSpring  v  7.3.1  (Agilent
Technologies).  Normalization  was  performed  using  the
Microarray  Suite  5  (MAS5)  algorithm  and  only  gene
expression levels with statistical significance (p<0.05) were
recorded as being “present” above background levels. Genes
with expression levels below this statistical threshold were
considered as “absent.” To determine the changes in gene
expression between control and hyperoxia treated retinas, we
treated the control RNA as a baseline control and expressed
changes relative to that control. Increases were determined for
genes that were considered present or absent in the control and
present in the hyperoxia sample; decreases were determined
for genes that were present in the control sample and present
or absent in the hyperoxia sample. Only fold changes of two
or greater were considered significant.
Replicate data were consolidated into groups based on
time exposed to hyperoxia (0, 3, 7 and 14 days) and organized
using the hierarchical clustering, ANOVA (ANOVA) and
gene ontology (GO) functions in the GeneSpring software.
Hierarchical  clustering  was  done  using  the  clustering
function (condition tree) in GeneSpring. All gene expression
levels were used as a gene list and experiments were organized
by both individual samples (to test sample reproducibility) as
well as groups (time exposed to hyperoxia). ANOVA analysis
was  performed  to  search  for  genes  which  varied  most
prominently  across  the  different  groups.  Microarray  were
analyzed using a parametric test and the cross gene error
model with a p-value cut-off set to 0.05. GO searches for
biologic processes were also performed, using data obtained
from initial GCOS twofold analysis to identify genes involved
in the response to stress and apoptosis.
qPCR: RNA for qPCR was handled in the same way as RNA
extracted for the GeneChip® experiments, with the exception
TABLE 1. LIST OF TAQMAN PROBES.
Gene symbol Gene name Catalogue
LIN7B Lin-7 homolog B Mm00457059_m1
EDN2 Endothelin 2 Mm00432983_m1
SIVA1 Apoptosis regulatory protein Siva Mm00834449_g1
BCL3 B-cell leukemia/lymphoma 3 Mm00504306_m1
OPN1SW Short-wave-sensitive opsin Mm00432058_m1
OPN1LW + OPN1MW Medium/long-wave-sensitive opsin Mm00433560_m1
RHO Rhodopsin Mm00520345_m1
C3 Complement component 3 Mm00437858_m1
DMD Dystrophin, muscular dystrophy Mm00464475_m1
PRPF3 Pre-mRNA processing factor 3 homolog Mm00510550_m1
GADD45β Growth arrest and DNA-damage-inducible 45 beta Mm00435123_m1
HIF1α Hypoxia inducible factor 1, alpha subunit Mm00468869_m1
GAPDH (Control) Glyceraldehyde-3-phosphate dehydrogenase Mm99999915_g1
List of all TaqMan probes used in this study to validate the microarray data. GAPDH was used as the normalizing control gene
for all comparisons.
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1984of group numbers. Three biologic groups were used, each
containing three animals at each time point. Superscript III
and the accompanying standard protocol (Invitrogen) were
used to convert 1 µg of retinal RNA to cDNA. TaqMan®
probes (Applied Biosystems, Foster City, CA) were used to
assess the validity of gene expression changes identified in the
microarray experiment (Table 1).
TaqMan® probes were applied following manufacturer’s
instructions with the Gene Expression Master-Mix (Applied
Biosystems), and the qPCR was performed on a Rotor-Gene
3000 and analyzed using the Rotor-Gene 6 software (Corbett
Robotics,  Mortlake,  NSW,  Australia).  For  each  biologic
sample, measurements were performed in duplicate and the
Ct  (cycle  threshold)  means  were  used  to  determine  fold-
change, using the Pfaffl Equation [20]. GAPDH primers were
employed to amplify a reference standard product that shows
no regulation by hyperoxia in this study. The fold change was
expressed relative to control (day 0 hyperoxia) values and
normalized to the reference gene (GAPDH).
RESULTS
Quality  Assessment—Samples  were  analyzed  for
validity against a set of criteria detailed in the Affymetrix Data
Analysis Manual. All samples met the specified criteria (Table
2).  Specifically,  GAPDH  5′/3′  ratios  were  less  than  3,
background  values  were  between  20  and  100,  the  noise
(RawQ), scale factors and percent present values were similar
in the replicates, and the percent present value was estimated
to be 50% for all samples.
Hierarchical  clustering  analysis—The  hierarchical
clustering  analysis  (Figure  1A)  showed  strong  replicate
clustering at day 0, day 3, and day 14. The day 7 replicates did
not cluster closely, however, suggesting biologic variability
at this time point. When the replicates were combined (Figure
1B),  the  clustering  analysis  showed  that,  overall,  gene
expression diverged steadily from control values with time of
exposure  to  hyperoxia,  with  the  day  14  sample  furthest
separate from the control.
Analyses  of  changes  in  gene  expression—Four
approaches  to  the  analysis  of  gene  expression  changes
induced by hyperoxia are summarized in Table 3. The first
approach tallied the genes for which expression had increased
or decreased by twofold or greater. The numbers of genes
whose expression change met this criterion increased steadily
during the hyperoxic treatment—from 1,177 at day 3 to 2,393
at day 7 to 3,102 at day 14. Decreases in expression were
prominent at all three time points and became more prominent
with time, with the decrease:increase ratio rising from 1.3 at
day 3, when photoreceptors were still resistant to hyperoxia,
to 2.3 at day 14, when photoreceptor degeneration was under
way.
The  second  approach  was  an  ANOVA  of  the  genes
identified by the twofold change criterion. This provided a list
of genes for which the difference from control values was
significant (p<0.05), for each time point. The number of genes
significantly  altered  increased  with  exposure  hyperoxia,
particularly at day 14 (Table 3).
In the third approach, we compared the list of genes which
met  the  twofold  criterion  with  the  list  of  genes  in  which
mutations cause photoreceptor dystrophy in humans (RetNet
database). This comparison identified 15 retinal disease genes
that were significantly regulated by hyperoxia at day 14.
In the fourth approach, we used the GO function of the
GeneSpring software to characterize functional groups of the
genes in the twofold criterion list. Prominent among those
functional groupings were genes associated with the response
of tissue to stress, and with apoptotic cell death.
TABLE 2. MEASURES OF SAMPLE AND DATA QUALITY.
Experiment #1 Day 0 Day 3 Day 7 Day 14
GAPDH 5′/3′ ratios 1.03 0.87 0.81 2.16
Background 43.41 55.04 37.47 39.53
Noise (rawQ) 1.34 1.69 1.16 1.19
Scale factor 1.765 1.524 2.785 2.586
Percent present 53.4 55 47.8 48
Experiment #2 Day 0 Day 3 Day 7 Day 14
GAPDH 5′/3′ ratios 1.11 0.79 1.03 2.44
Background 43.77 53.3 42.76 40.21
Noise (rawQ) 1.36 1.67 1.31 1.24
Scale factor 1.68 1.533 1.808 2.376
Perecent present 54.7 54.9 51.4 47.5
The quality of each chip was evaluated using standardized criteria including 5′/3′ ratio of GAPDH, background, noise (rawQ),
scale factor, and percent present. All values met the required criteria.
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1985qPCR validation: Six genes from the list isolated by ANOVA
analysis of the GeneChip® results (Appendix 1) were selected
for analysis by qPCR: B-cell leukemia/lymphoma 3 (BCL-3;
apoptosis-related),  Complement  component  3  (C3;
complement cascade), Glial fibrillary acidic protein (GFAP;
response to stress), Endothelin 2 (Edn2; vasoconstriction),
Lin-7 homolog B (Lin7b; channel maintenance), and Growth
arrest  and  DNA-damage-inducible  45  beta  (Gadd45b;
apoptosis). They represent several functional groups and were
strongly regulated by hyperoxia. In addition, three genes were
chosen from the twofold criterion list as genes of interest in
hyperoxic  stress:hypoxia-induced  transcription  factor
(HIF1α), free radical scavenger (Oxr-1 [18]) and apoptosis-
inducing (Siva). Three other genes were chosen for study,
because they showed changes in expression of <2 fold (no
change) in the GeneChip data: rhodopsin, L/M opsin, and S
opsin. These genes were chosen to validate a group of known
retinal expressed genes (opsins) that exhibited no change in
this study. Three genes were chosen from a group of human
retinal disease genes (see Table 4): C3 (already included),
Figure  1.  Hierarchical  clustering
diagrams showing individual replicates
(A) and pooled data (B). Panel A shows
strong  replicate  clustering  at  all  time
points  except  7  days,  while  Panel  B
shows that the change of global gene
expression  is  continual  with  the
exposure to oxygen.
TABLE 3. NUMBERS OF GENES CHANGING EXPRESSION WITH HYPEROXIA.
  Time in hyperoxia
3 days 7 days 14 days
Increased expression 509 967 933
Decreased expression 668 1426 2169
Total genes changing expression 1177 2393 3102
ANOVA 18 19 95
Retinal Disease Genes 0 0 15
GO: Response to stress 58 108 196
GO: Apoptosis-related 45 81 101
The number of genes regulated by hyperoxia, over a 14 day exposure, with a change of ±2 fold or greater is shown. The data
were further analyzed and divided into catagories based on several criteria, including gene increases (first row), decreases (second
row), total number of gene changes (third row), number of genes with a p<0.05 (ANOVA; fourth row) and genes associated
with human retinal diseases (fifth row). Using Gene Ontology (GO), those genes associated with stress (sixth row) and apoptotic
cell death (seventh row) were also determined.
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1986dystrophin, muscular dystrophy (DMD) and PRP3 pre-mRNA
processing factor 3 (Prpf3). GAPDH was included, as a gene
with constant expression during hyperoxia.
For each of these 15 genes, the fold changes observed by
qPCR (Figure 2) and in the GeneChip analysis are shown in
Table 5. The magnitude of the change varied considerably
between the two techniques but, with three exceptions, the
direction of the change was the same in the two assessments.
The three exceptions were C3 at day 7 (correlated at day 3 and
day 14 but diverged at day 7), HIF1α (diverged at day 14), and
Prpf3 (no correlation with GeneChip data).
Functional  groupings  of  oxygen-induced  genes:  From  the
genes identified in this study to be regulated by hyperoxia,
many functional groupings are possible. Three are considered
in more detail here because of their relevance to photoreceptor
degeneration
Figure  2.  Assessment  by  qPCR  of  expression  changes  in  genes
identified by microarray analysis as hyperoxia-regulated. As noted
for Table 5, these data validate trends in the Genechip data. A:
Validation of human retinal disease genes showing upregulation of
C3, downregulation of DMD and no change to Prpf3. B: Control
genes  (opsins)  which  showed  no  change  in  expression.  C-E:
Additional sets of genes assessed by qPCR. C shows a group of three
genes upregulated at 14 day. D shows a group upregulated at all time
points; E shows contrasts a gene (Oxr1) upregulated at 3 day, with
GFAP, which is maximally upregulated at 14 day. For each gene, the
fold change in expression was determined using 0 day expression as
control and normalizing the data to the housekeeping gene GAPDH.
Fold changes below the dashed line indicate expression decrease
while above the line indicate expression increase. Error bars show
standard error of the mean.
Human retinal disease genes: The 15 retinal disease genes
that were upregulated at day 14 exposure are shown in Table
4. Only one of the 15 is known to be retina specific: Regulator
of G-protein signaling 9 (RGS9) is a photoreceptor specific
member of a family of proteins that deactivate transducins.
The other genes are more ubiquitous, although some, such as
DMD and Retinitis pigmentosa GTPase Regulator (RPGR),
may have retina-specific isoforms..
Stress-related genes: As noted, the number of stress-related
genes  whose  expression  was  significantly  changed  by
hyperoxia increased from 58 at day 3 exposure to 196 at day
14 (Appendix 1). Figure 3 breaks the GO-identified response-
to-stress genes into biologic subgroupings.
In all subgroupings except oxidative stress, the number
of genes regulated by hyperoxia increased with exposure, and
was maximal at day 14. Within this overall trend, however,
there was a significant shift in the subgroups regulated. At day
3, for example, the most numerous subgroup was of genes
relating to DNA damage; at day 14, by contrast, genes relating
to damage (“wounding” and “pest, pathogens, and parasites”)
had become numerically dominant. Again, at day 7 the values
were  intermediate.  Genes  significantly  regulated  at  day  3
included genes responsive to hypoxia and oxidative stress
Hif1α  (3.48),  the  antihemophilic  Von  Willebrand  factor
(Vwf; −3.09), a suppressor of apoptosis thymoma viral proto-
oncogene  1  (Akt1;  2.31),  the  angiogenesis-related
Thrombospondin  1  (Thbs1;  3.41),  and  DNA  repair
antiapoptotic Heat shock 70 kDa protein 1B (Hspa1b; −2.09).
Genes significantly regulated at day 14 included an initiator
of apoptosis BCL-3 (46.57), a suppressor of apoptosis Akt1
(−7.52),  Hif1α  (−3.37),  and  members  of  the  complement
cascade,  including  complement  component  1,  q
Figure 3. Genes for which expression was up- or downregulated by
twofold or more. These were separated into the subgroupings of the
gene ontology (GO) category “response to stress.” The number of
genes  regulated  by  hyperoxia  increased  with  exposure  and  was
maximal at day 14 in all subgroupings, except oxidative stress, which
was maximal at day 7.
Molecular Vision 2008; 14:1983-1994 <http://www.molvis.org/molvis/v14/a234> © 2008 Molecular Vision
1987subcomponent, alpha (C1qa; 2.37), complement component
1,  q  subcomponent,  beta  (C1qb;  4.56),  complement
component  1,  q  subcomponent,  gamma  (C1qg;  6.43),
Complement  component  3  (C3;  10.42),  and  Complement
component 3 (C4; 5.41)
Apoptosis-related genes: Significant trends in regulation were
also apparent among genes related to apoptosis (Figure 4).
First, the overall number of apoptosis-related genes whose
expression was oxygen-regulated increased with exposure,
including both death-promoting and death-inhibiting genes
(Figure  4A).  Second,  when  increases  and  decreases  in
expression were separated (Figure 4B,C), then at day 14, when
photoreceptor death was prominent, the number of apoptosis
inhibitors whose expression was increased fell; the number of
apoptosis promoters whose expression was increased rose
sharply. That is, the machinery of cell death had become
predominant, within the overall increase shown in Figure 4A.
Among the death promoter genes that became prominent at
day 14 exposure were B-cell leukemia/lymphoma 3 (Bcl3),
Bcl2  interacting  killer-like  (Biklk),  Caspase  7  (Casp7).
Prominent among the death-inhibitor genes whose expression
fell at day 14 were apoptosis inhibitor 5 (Api5), insulin-like
growth factor 1 (Igf1r) and Akt1.
Pathways  analysis  of  stress  response:  To  identify  stress-
related pathways significantly regulated by hyperoxia, we
used GO (Figure 4) to analyze the response-to-stress genes
identified  as  regulated  by  hyperoxia  using  Database  for
Annotation,  Visualization  and  Integrated  Discovery
(DAVID).  This  analysis  identified  two  stress-related
pathways as significantly regulated: 1) the “Inactivation of
Gsk3 by AKT causes accumulation of β-catenin in Alveolar
Macrophages (BIOCARTA) pathway,” which is important in
macrophage  activation;  and  2)  the  Complement  and
Coagulation  Cascades  (KEGG)  pathway  (KEGG  #:
mmu04610).
Regulation of the “Inactivation of Gsk3 by AKT causes
accumulation  of  β-catenin  in  Alveolar  Macrophages
pathway”  was  evident  at  all  three  periods  of  exposure  to
TABLE 4. GENES INVOLVED IN HUMAN RETINAL DISEASE THAT WERE FOUND TO BE REGULATED BY 14-DAY HYPEROXIA.
Probe ID Gene symbol Gene title Fold change
1439083_at AHI1 Abelson helper integration site −2.805
1447156_at CHM Choroidermia (Chm), mRNA −4.097
1423954_at C3 Complement component 3 10.41
1421451_at CRB1 Crumbs homolog 1 (Drosophila) −2.381
1417307_at DMD Dystrophin, muscular dystrophy −5.376
1448665_at DMD Dystrophin, muscular dystrophy −2.298
1446156_at DMD Dystrophin, muscular dystrophy (DMD), mRNA −4.319
1438251_x_at HTRA1 HtrA serine peptidase 1 2.04
1445740_at MASS1 Monogenic, audiogenic seizure susceptibility 1, mRNA (cDNA
clone IMAGE:5050650)
−2.816
1451062_a_at PEX2 Peroxin 2 −2.493
1446144_at PEX2 Peroxin 2 −2.47
1437443_at PXMP3 Peroxisomal membrane protein 3, mRNA (cDNA clone MGC:
11449 IMAGE:3964491)
−2.192
1421381_a_at COL9A1 Procollagen, type IX, alpha 1 −2.164
1418599_at COL11A1 Procollagen, type XI, alpha 1 −2.151
1442326_at PCDH15 Protocadherin 15 −3.879
1457390_at PRPF3 PRP3 pre-mRNA processing factor 3 homolog (yeast) (Prpf3),
mRNA
−5.155
1439635_at RGS9 Regulator of G-protein signaling 9 −2.126
1427467_a_at RPGR Retinitis pigmentosa GTPase regulator −2.808
1451785_at RPGRIP1 Retinitis pigmentosa GTPase regulator interacting protein 1 −2.651
1431357_a_at RPGRIP1 Retinitis pigmentosa GTPase regulator interacting protein 1 −2.547
1454231_a_at Rpgrip1 Retinitis pigmentosa GTPase regulator interacting protein 1 −2.39
1456449_at Rpgrip1 Retinitis pigmentosa GTPase regulator interacting protein 1,
mRNA (cDNA clone IMAGE:4504262)
−21.15
1448411_at Wfs1 Wolfram syndrome 1 homolog (human) 2.07
Listed are human retinal disease genes whose expression was found to change by greater than twofold after a 14-day exposure
to hyperoxia. List was generated from RetNet  database. Red underline marks genes validated by qPCR.
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1988hyperoxia examined. At day 3, Akt1 (2.31), toll interacting
protein (Tollip; 3.65), Gap junction protein, alpha 1, (Gja1;
2.29) all increased expression, while at day 7 regulated genes
included Akt1 (2.00), Gja1 (4.50), and Glycogen synthase
kinase 3 beta (Gsk3b; −2.13) and at day 14, adenomatosis
polyposis coli (Apc; −6.99), Akt1 (−7.52), Gja1 (2.37), Tollip
(−2.17), lymphocyte antigen 96 (Ly96; −3.60), and Gsk3b
(−2.04). One of the key roles of this pathway is the action of
Akt1 in inhibiting apoptosis, through interactions with NFκB;
Akt1 was upregulated at day 3 and day 7, but downregulated
at day 14. Another key role is the interaction of Gsk3b and
Apc,  two  of  the  three  components  (the  third  being  axin)
required  for  phosphorylation  of  β-catenin.  This
phosphorylation targets β−catenin for degradation, reducing
its effect in inhibiting apoptosis.
Regulation of genes involved in the Complement and
Coagulation Cascade pathway was significant principally at
day 14 exposure to hyperoxia, the regulated genes including
C1qa (2.37), C1qb (4.56), C1qg (6.43), C3 (10.42), C4 (5.41),
Serpinc1 (21.65), and Serping1 (5.26). None of these genes
was  regulated  significantly  at  shorter  exposure  times.
Outcomes  of  the  complement  cascade  include  cell  lysis,
phagocyte recruitment, and inflammation.
DISCUSSION
Hyperoxia is an established feature of the retina undergoing
photoreceptor degeneration. In retinitis pigmentosa, the effect
of raised oxygen levels is apparent as a slowly progressive
thinning  of  the  retinal  vasculature.  In  animal  models,  the
increase in tissue oxygen levels in the photoreceptor layers
caused by degeneration has been measured directly [14–16];
a comparable thinning of vessels has been observed and has
been shown to be reversed by hypoxia. Further, hyperoxia is
toxic to photoreceptors [9–13], raising the possibility that
depletion-induced hyperoxia contributes to the progress of the
retinal degenerations. This study is the first to provide an
overview of gene expression changes induced in the retina by
sustained hyperoxia.
Summary of findings: The total number of genes showing
altered (upregulated or down-regulated) expression increased
in response to hyperoxia in the C57BL/6J mouse retina during
a 14 day exposure period. At day 3, the numbers of genes
increasing or decreasing expression were approximately equal
(509 versus 688); by day 14, the number of regulated genes
had  tripled,  and  those  decreasing  expression  had  become
numerically  dominant  (933  increasing  versus  2169
decreasing). A hierarchical clustering analysis confirmed this
change  as  progressive  and  consistent,  with  inconsistency
greatest (suggesting a transition point) at day 7 exposure.
Genes  in  which  mutations  were  known  to  cause
photoreceptor dystrophy (RetNet database) were hyperoxia-
regulated only at the day 14 exposure time point. Of these, 15
were identified (Table 4).
TABLE 5. COMPARISON OF GENECHIP AND QPCR DATA.
 
Gene
qPCR                                                                             GeneChip
Day 3 Day 7                      Day 14 Day 3 Day 7                  Day 14
BCL-3 1.21 1.03 3.66 NC NC 4.1
C3 −1.11 1 2.8 NC −6.21 10.42
Edn2 1.46 1.48 4.71 2.93 NC 13.15
Gadd45b 1.37 1.77 3.35 NC NC 4.54
GFAP −1.33 2.14 7.2 NC 2.31 16.64
HIF1a 1.5 1.4 1.1 3.48 NC −3.37
Lin7b 1.72 1.45 1.96 NC NC 4.39
L/M-opsin 1.4 1.2 1.1 NC NC NC
Oxr1 1.83 1.08 −1.25 3.3 NC −2.6
Rhodopsin −1.11 1 −1.11 NC NC NC
Siva 1.47 1.45 1.42 NC NC 2.3
S-opsin 1 1 1 NC NC NC
DMD −1.25 −1.23 −2 NC NC −5.38, −2.3, −4.13
Prpf3 1.1 1 1 NC NC −5.2
GAPDH* 1 1 1 NC NC NC
Generally, genes showed the same trend in regulation in the qPCR and microarray experiments, but not necessarily by the same
fold change. No change (NC) refers to a gene whose expression was below twofold for the microarray experiment and therefore
the results were not statistically significant. The asterisk indicates a housekeeping gene. Validation, using qPCR, of genes linked
to human retinal diseases were found to have differential expression at day 14 exposure to hyperoxia. Multiple entries indicate
multiple probe identification (ID)’s from the GeneChip® analysis. Note that Prpf3  did appear to change when tested using
qPCR.
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1989When stress-related genes were considered separately,
the  number  regulated  increased  with  time  of  exposure  to
hyperoxia,  to  be  maximal  at  day  14.  Within  that  overall
pattern, however, there was a significant shift with time, with
DNA-damage-related genes numerically dominant at day 3,
and  genes  relating  to  tissue  damage  (wounding;  pests,
pathogens, and parasites) numerically dominant at day 14.
Figure  4.  Number  of  regulated  genes,  total,  upregulated,  and
downregulated, is shown by Gene Ontology at 3, 7 and 14 days. The
total number (A) of apoptosis-related genes is maximal at 14 days
for all subgrouping except for ‘negative regulation of programmed
cell death’ which peaks at 7 days. The number of upregulated (B)
and downregulated (C) genes increases over the 14 day treatment
period in each ontology category except in (B) where ‘negative
regulation of programmed cell death’ is maximal at 7 days. This
indicates a loss in potential protective mechanisms against apoptosis
in the hyperoxic mouse retina.
When  apoptosis-related  genes  were  considered
separately, the number of genes regulated increased with time
of exposure, to be maximal at day 14. Within that overall
increase, again, there was a significant shift with time, with
apoptosis-inhibiting genes dominant at day 3, and apoptosis-
promoting genes dominant at day 14.
Finally, among the stress-related genes, pathway analysis
identified significant regulation of two signaling pathways:
one  related  to  macrophage  activation,  and  one  to  the
regulation of the complement cascade.
Phases in the retina’s response to hyperoxia: Previously
[18], we have argued that the response of the C57BL/6J retina
to sustained hyperoxia comprises successive early and late
phases.  In  the  early  phase,  at  day  3  exposure,  protective
mechanisms are prominent, while the later stage (day 14) is
dominated by the response to tissue damage.
The present results support this two-phase analysis in
several  ways.  In  the  hierarchical  clustering  analysis,  for
example, cladistic separation was maximal between the day 3
and day 14 data; the day 7 replicates showed greater internal
separation than the replicates at the other three time points. As
previously reported [18] the day 7 time point in this model
appears to be transitional. The shifts noted above between day
3 and day 14 in the expression of photoreceptor dystrophy
genes (regulated only at day 14), of stress-related genes (from
DNA-related to damaged-related), of apoptosis-related genes
(from inhibiting to promoting) all support this idea of early
and late phases. Relating these changes to retinal structure, we
find photoreceptors remained stable at day 3 exposure, show
signs of degeneration at day 7 and show considerable loss and
continuing cell death at day 14.
Relating this pattern to individual genes, it is evident that
at day 14 the genes responsible for the early stability of the
retina were switched off, and genes that cause instability are
switched on. For example, the microarray data indicated that
Hif1α,  Akt1,  and  Oxr1  were  upregulated  at  day  3,  and
downregulated by day 14; conversely, BCL-3, Gadd45b, C3,
Lin7b, and Edn2 were all upregulated late in the 14-day period
examined.
Functional  roles  of  early-  and  late-responsive  genes:
examples: Hif1α, identified by the functional annotation tool
of GeneSpring as a response-to-stress gene, is an established
hypoxia-induced transcription regulator, thought to regulate
the expression of at least 40 genes [21]. The genes regulated by
Hif1α play a pivotal role in tissue adaptation changes in their
local  oxygen  and  metabolic  environment.  The  evidence
presented here suggests that Hif1α is regulated by hyperoxia,
as well as hypoxia, and act during the early stages of hyperoxia
(three days), before photoreceptor damage.
Akt1 is identified by GeneSpring as being both stress- and
apoptosis-related. It is a protein kinase known to initiate NF-
κβ, an important proinflammatory transcription factor, and
has  been  shown  to  protect  hippocampal  neurones  from
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1990hypoxia- and nitric oxide-mediated cell death [22]. AKt1 has
been found to be upregulated in response to retinal injury, and
appears to be part of a neuroprotective response [23]. Akt1
protein is known to interact with BCL-3 protein, preventing
its phosphorylation through inhibition of Gsk3, and slowing
its subsequent degradation [24]. BCL-3 is an oncogene which
functions as a nuclear transcriptional activating factor that
activates NF-κβ target genes. Akt1, Gsk3, and BCL-3 have
been implicated in the pathway “Inactivation of Gsk3 by AKT
causes accumulation of b-catenin in Alveolar Macrophages.”
Little is known of the role of Gadd45b or Lin7b in the
retina.  Gadd45b  responds  to  environmental  stresses  by
mediating activation of the p38/JNK pathway [25,26] but has
not yet been studied in the central nervous system. It may
[27] act as an antiapoptotic gene regulated by NF-κβ. Lin7b
is  a  polarity-related  gene,  and  has  been  identified  as  a
interactive  partner  of  Rhotekin  (an  effector  of  Rho)  and
playing  a  role  in  neuronal  function  [28].  Lin7b  might  be
involved in synapse function as it has been found to associate
with the neuronal cadherin-β-catenin complex [29]. Increases
in both Gadd45b and Lin7b at day14 indicate a potential role
in neuronal survival.
Edn2 and GFAP may function as general stress response
genes in the retina. Edn2 is a member of a vasoconstrictor
family of genes and has been found to signal Müller cells in
the stressed retina by binding to EDNRB [30]. GFAP is a
stress-induced  intermediate  filament  protein  expressed  by
astrocytes  and,  under  stress,  by  Müller  cells  [31,32].
Upregulation of these genes at day 14 confirms the stress
caused by hyperoxia. Further work, specific to individual
genes, will be required to define their roles more clearly.
Hyperoxia-regulated  retinal  disease  genes:  examples:
The present study provides evidence that hyperoxia regulates
15 genes in which mutations are known to cause photoreceptor
dystrophy.  For  example,  DMD  is  an  X-linked  recessive
neuromuscular disease affecting skeletal, cardiac and smooth
muscle function as well as the central nervous system. In the
retina, mutations in DMD lead to reduction in rod b-wave
amplitude but normal a-wave, photoreceptor morphology and
visual acuity [33]. This suggests that a mutation in DMD
causes a breakdown in retinal processing of photoreceptor
signals.
C3 forms part of the complement cascade and has been
implicated, along with other proteins of the cascade, in several
inflammatory  diseases  including  age-related  macular
degeneration and Alzheimer disease [34–36]. In this study,
genes for proteins in the classical (C1qa,C1qb,C1qg,C4, and
Serping1) and alternative cascade (C3) have been shown to
be upregulated at 14-day exposure to hyperoxia. C3 has been
found to be expressed in RPE cells, and accumulation of C3
protein has been found in a knockout of CFH−/− mouse, in the
photoreceptor outer segments [37]. Mutations in CFH cause
accumulation of C3 in RPE cells, and it is this accumulation
that leads to inhibition of transduction and possibly cell death
[37].  It  is  possible  that  hyperoxia  causes  a  comparable
accumulation of C3.
Paradox: how does hyperbaric oxygen treatment slow
retinal  degenerations:  It  seems  counter  to  the  evidence
discussed above of the toxicity of hyperoxia to photoreceptors
that hyperbaric oxygen therapy (HBO) has been reported to
improve the ERG in humans affected by retinitis pigmentosa,
and to slow the progress of the degenerations [38]. In HBO,
the retina (indeed the whole body) is exposed to very high
partial pressures of oxygen achieved by exposing the patient
to 100% oxygen under 2–3 atmosphere of pressure (atm).
Although  hemoglobin  is  close  to  saturated  in  normobaric
normoxia  (21%  oxygen  at  1  atm),  the  partial  pressure  of
oxygen  in  body  fluids  is  increased  several-fold  in  HBO.
Typically, HBO is given for 1–2 h daily, for 5 days per week.
In the trials reported by Vingolo and colleagues, patients were
given 100% oxygen at 2.2 atm for 90 min, 3 times a day and
5  days  a  week  for  a  month,  then  for  5  consecutive  days
monthly for 11 months, then for 5 consecutive days every 3
months for up to 9 years.
The early-late phase analysis of the C57BL/6J retina’s
response  to  hyperoxia  gives  a  clue  as  to  why  HBO  may
provide benefit to some patients. Because exposure times are
short (1–2 h) compared to the early and late phases discussed
here (measured in days), it is possible that HBO elicits the
early  phase  genes  by  repeated,  successive  episodes  of
hyperoxia.  Further  experimentation  is  needed  to  test  this
possibility;  if  confirmed,  this  suggestion  would  provide  a
mechanistic  hypothesis  for  the  beneficial  effects  of  the
extreme oxygen tensions generated by repeated episodes of
HBO.
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1993Appendix 1. Genes identified as hyperoxia regulated using ANOVA
To access the data, click or select the words “Appendix
1.” This will initiate the download of a pdf file archive that
contains the file.
The  genes  listed  were  identified  using  ANOVA  as
hyperoxia-regulated by two criteria: a greater than twofold
change and a p value < 0.05. The genes highlighted in red were
examined by qPCR to validate the GeneChip® results. These
include  BCL-3,  C3,  GFAP,  Edn2,  Lin7b,  and  Gadd45b.
Increases are highlighted in black bold, and decrease are in
normal text. NC=No change.
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